These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23520914)

  • 21. Patent protection for stem cell procedures under the law of the European Union.
    Spranger TM
    Med Etika Bioet; 2003; 10(1-2):4-8. PubMed ID: 16294439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Summoning a New Artificial Intelligence Patent Model: In The Age Of Pandemic.
    Yanisky-Ravid S; Jin R
    SSRN; 2020 Jun; ():3619069. PubMed ID: 32714121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The patentability of human beings: the effect of a proposed exclusion in the Patents Act 1953.
    MacBean A
    Law Rev; 2002 Nov; 33(2):379-407. PubMed ID: 15212079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patentability of Parthenogenic Stem Cells: International Stem Cell Corporation v. Comptroller General of Patents.
    Mansnérus J
    Eur J Health Law; 2015 Jun; 22(3):267-86. PubMed ID: 26399046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive.
    Van Overwalle G
    Rev Derecho Genoma Hum; 2003; (19):187-203. PubMed ID: 15032104
    [No Abstract]   [Full Text] [Related]  

  • 26. The immoral gene: does it really exist?
    Zimmer FJ; Sethmann S
    Sci Eng Ethics; 2005 Jan; 11(1):97-104. PubMed ID: 15727005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Patent protection in modern medical technology].
    Bosch M
    Biomed Tech (Berl); 2002; 47 Suppl 1 Pt 2():686-7. PubMed ID: 12465274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biotechnological invention patents: a legal-economic analysis].
    Pérez-Bustamante G
    Rev Derecho Genoma Hum; 1998; (8):159-86. PubMed ID: 15839032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patents in Nanobiotechnology: A Cross Jurisdictional Approach.
    Manchikanti P; Uppala S; Bonta RK
    Recent Pat Biotechnol; 2017; 11(1):52-70. PubMed ID: 27881055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patents, Governance and Control: Ethics and the Patentability of Novel Beings and Advanced Biotechnologies in Europe.
    McMahon A
    Camb Q Healthc Ethics; 2021 Jul; 30(3):529-542. PubMed ID: 34109920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intellectual property in natural sciences].
    Twardowski T
    Postepy Biochem; 2008; 54(1):20-3. PubMed ID: 18610578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotechnology and law: biotechnology patents. Special considerations on the inventions with human material.
    Simon J
    Rev Derecho Genoma Hum; 2006; (25):139-59. PubMed ID: 17393801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The generic Research and Development possibilities after Hungary accessed th European Patent Convention].
    Kelen A; Angyal N; Máthé Z; Bódis A; Hódi K
    Acta Pharm Hung; 2003; 73(2):123-9. PubMed ID: 14702693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impact of synthetic biology on patent law in view of of European jurisprudence].
    Bernardo Alvarez MA
    Rev Derecho Genoma Hum; 2014; (41):123-40. PubMed ID: 25845209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To be or not IP? Exploring limits within patent law for the constitutionalization of intellectual property rights and the governance of synthetic biology in human health.
    Schneider I
    Rev Derecho Genoma Hum; 2012; (37):193-233. PubMed ID: 23520920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patentable invention in biotechnology.
    Rudolph JR
    Biotechnol Adv; 1996; 14(1):17-34. PubMed ID: 14536922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Japan's patent issues relating to life science therapeutic inventions.
    Tessensohn JA
    Expert Opin Ther Pat; 2014 Sep; 24(9):953-7. PubMed ID: 25089628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revocation of European patent for neural progenitors highlights patent challenges for inventions relating to human embryonic stem cells.
    Rigby B
    Expert Opin Ther Pat; 2013 Nov; 23(11):1395-8. PubMed ID: 24079708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patent law for the dermatologist.
    Mei DF; Liu J
    Semin Cutan Med Surg; 2013 Dec; 32(4):242-6. PubMed ID: 24800434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.
    Huys I; Van Overwalle G; Matthijs G
    Eur J Hum Genet; 2011 Oct; 19(10):1104-7. PubMed ID: 21654725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.